B cell depletion therapy
The importance of B cells in autoimmune diseases has been well documented [2] [3] [4] . B cells contribute to the disease process as antigen presenting cells, through costimulatory functions (surface molecules, secreted cytokines and interaction with chemokines) as well as by secreting pathogenic antibodies. Recent success in B cell depletion therapies especially using anti-CD20 antibodies (rituximab) in autoimmune diseases for example RA and SLE is encouraging [5] [6] [7] [8] . However, it takes a long time before the antibody levels in serum decreases and an ameliorative effect on disease is seen. Antibodies remains in circulation, probably produced by long-lived plasma cells in the bone marrow [9] where they have to receive survival signals from stromal cells [10] . FcγRIIB was found to be critical for prevention of generation and expansion of autoreactive antibody secreting IgG positive plasma cells [11] and cross-linking this inhibitory receptor on plasma cells in the bone marrow to induce apoptosis has been suggested as a means to reduce the pathogenic antibodies in circulation [12, 13].
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Antibody functions and autoimmunity
The antibody (humoral) response in vertebrates is produced against foreign structures and is intended for the protection of hosts against invading pathogenic microorganisms but excessive activation to overcome self-tolerance or misguided immune activation leads to generation of self-reactive antibodies that are potentially pathogenic. It is clear that the presence of autoantibodies precedes the onset of autoimmune diseases in humans, for example in type 1 diabetes and arthritis [6, 14] . Apart from being diagnostic and 
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